ZZ Biotech
Houston, US · 1 known investors
Find your way into ZZ Biotech
ZZ Biotech develops 3K3A-APC, a genetically engineered variant of human activated protein C (a serine protease) optimized for therapeutic use. The company has agreed in principle to license its 3K3A-APC dermatology program to Dermatherix for wound therapy applications.
Investors · 1
Frequently asked questions
- What does ZZ Biotech do?
- ZZ Biotech develops 3K3A-APC, a genetically engineered variant of human activated protein C (a serine protease) optimized for therapeutic use. The company has agreed in principle to license its 3K3A-APC dermatology program to Dermatherix for wound therapy applications.
- Who are ZZ Biotech's investors?
- ZZ Biotech's investors include Broadview Ventures.
- Where is ZZ Biotech headquartered?
- ZZ Biotech is headquartered in Houston, US.